Lilly and Novo trial data show GLP-1s reduce biological age, reports MIT Tech Review
MaxUnfried · x · 2026-10-08
At the ARDD conference, MIT Technology Review's Antonio Regalado broke the news that both Lilly and Novo presented data from massive trials showing GLP-1s reduce biological age measured by methylation and proteomics — a long-expected result now backed by evidence.
More from Research
- MIKE: researchers open-source compact post-quantum NIKE with 80-byte public keys — jedisct1 · 2026-10-08
- KITE transfers robot task knowledge across hands zero-shot, hitting 7/10 on real hardware — qinzytech · 2026-10-08
- NeurIPS paper: humanoids should imagine in 360° instead of thinking longer to find objects — _vztu · 2026-10-08
- Stanford's Anshul Kundaje Slams 'Universal Virtual Cell': Perturbation Prediction Is the Wrong Metric — anshulkundaje · 2026-10-08
- Kernaut: coding agents design Gaussian process kernels via program search — sirbayes · 2026-10-08
- Kernaut's discovered kernels stay interpretable: 16 scalar functions, inner-product form — sirbayes · 2026-10-08